City

Kingston (1)

Philadelphia (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

laboratory biomarker analysis (2)

temsirolimus (1)

thalidomide (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

NIH (2)

Study Type

Interventional (2)

endometrial adenosquamous cell carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma Trial in Kingston

Completed

Endometrial Adenocarcinoma
+9 more

temsirolimus
laboratory biomarker analysis

Kingston, Ontario, Canada

National Cancer Institute of Canada Clinical Trials Group

Feb 5, 2015

Endometrial Adenoacanthoma, Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma Trial in Philadelphia

Completed

Endometrial Adenoacanthoma
+5 more

thalidomide
laboratory biomarker analysis

Philadelphia, Pennsylvania

Gynecologic Oncology Group

Jan 23, 2013